Molecular Partners is a Switzerland-based biotechnology company that develops and commercializes custom-built protein therapeutics for the treatment of cancer.
Business Model:
Revenue: $10.7M
Employees: 51-200
Address: Wagistrasse 14
City: Schlieren
State: zurich
Zip: 8952
Country: CH
Molecular Partners is a Switzerland-based biotechnology company that develops and commercializes custom-built protein therapeutics for the treatment of cancer.
Contact Phone:
Contact Email:
Listed Exchange:
SIX Swiss Exchange
IPO Date:
6/16/2021
IPO Valuation:
$683M
Ticker Symbol:
MOLN
IPO Price:
$21.25/share
Amount Raised:
$64M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|